V-Square Quantitative Management LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1943239 CHICAGO, IL

Position in VRTX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$2,747,413

+$199,456 QoQ

Shares Held

5,531

-3.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#601

of 1,735 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 43% Shared 0% None 57%

Healthcare · as of Jun 30, 2026

V-Square Quantitative Management LLC holds $6,143,388 across 14 Biotechnology names. VRTX ranks #1 (44.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	5,531	$2,747,413
2	ALNY	Alnylam Pharmaceuticals, Inc.	2,211	$665,577
3	REGN	Regeneron Pharmaceuticals, Inc.	1,025	$639,128
4	INCY	Incyte Corp	5,417	$614,071
5	MRNA	Moderna, Inc.	6,532	$457,435
6	TECH	BIO-TECHNE Corp	6,197	$437,818
7	RPRX	Royalty Pharma plc	6,318	$354,250
8	EXEL	Exelixis, Inc.	1,037	$56,423

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,747,413	5,531	-3.1%	Shares	Sole	2026-07-27
2026-03-31	$2,547,957	5,706	+1.5%	Shares	Sole	2026-04-27
2025-12-31	$2,549,696	5,624	-5.8%	Shares	Sole	2026-01-22
2025-06-30	$2,657,844	5,970	+45.8%	Shares	Sole	2025-07-17
2025-03-31	$1,985,337	4,095	-2.2%	Shares	Sole	2025-05-13
2024-12-31	$1,685,702	4,186	+13.2%	Shares	Sole	2025-01-30
2024-09-30	$1,719,400	3,697	+6.0%	Shares	Sole	2024-10-17
2024-06-30	$1,635,364	3,489	+1.4%	Shares	Sole	2024-07-16
2024-03-31	$1,437,954	3,440	+44.1%	Shares	Sole	2024-04-24
2023-12-31	$971,653	2,388	+103.4%	Shares	Sole	2024-02-21
2023-09-30	$408,246	1,174	+90.3%	Shares	Sole	2023-11-13
2023-06-30	$217,128	617	-70.9%	Shares	Sole	2023-07-26
2023-03-31	$668,578	2,122	—	Shares	Sole	2023-04-24
No filing history on record for this holder in this stock.